QLT INC/BC

CIK 827809 · last filed 2016-04-07

QLT INC/BC is a corporate insider who has filed 1 SEC Form 4 insider transactions across 1 company since 2016. The most recent filing shows the insider sold $15.0M of ARLZ on Apr 7, 2016. Across all open-market trades the lifetime net is −$15.0M, making them a net seller over the disclosed history. The firm reports its address in Vancouver, A1. 34 SEC filings were submitted jointly with Public Equity K/S NB.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$0

Companies

1

Total Filings

1

Lifetime Open-Market Net

-$15.00M

Filer Profile

Reported Address

C/O NORTON ROSE FULBRIGHT
1800 - 510 WEST GEORGIA STREET
VANCOUVER, A1 V6B 0M3

Phone

(877) 764-3131

State of Incorporation

British Columbia, Canada

Formerly Known As

QLT INC/BC (2000–2016)

QLT PHOTO THERAPEUTICS INC (1996–2000)

QLT PHOTOTHERAPEUTICS INC (1996–1996)

QUADRA LOGIC TECH. INC. (1994–1994)

Related Filers

Public Equity K/S NB — 34 joint filings, latest 2020-01-21

Jason Aryeh — 22 joint filings, latest 2017-05-17

Broadfin Capital, LLC — 15 joint filings, latest 2020-01-15

ELIAV ASSOULINE — 14 joint filings, latest 2015-06-17

Benjamin Harshbarger — 12 joint filings, latest 2019-05-13

Jeffrey A Meckler — 11 joint filings, latest 2016-06-21

BIOTECHNOLOGY VALUE FUND L P — 10 joint filings, latest 2016-07-05

GEOFFREY F COX — 10 joint filings, latest 2016-12-27

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
Aralez Pharmaceuticals Inc. (ARLZ) Delisted	10%+ Owner	4,800,000	—	—	-$15.00M	1	2016-04-07

Recent Filings

1 filing

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2016-04-07	Aralez Pharmaceuticals Inc. (ARLZ) Delisted	Sell (S)	−2,400,000	-$15.00M	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.